Literature DB >> 19622445

Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance.

G Nicoletti1, D Nicolosi, G M Rossolini, S Stefani.   

Abstract

Intra-abdominal infections (IAIs) are commonly encountered in clinical practice. The etiology of these infections, often polymicrobial in nature, can be variable and usually includes organisms derived from the gut microbiota. in community-acquired IAIs enterobacteria predominate (mostly Escherichia coli) in combination with anaerobes (mostly Bacteroides fragilis). In nosocomial IAIs, which can complicate abdominal surgery, other pathogens can also play a role, such as Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus spp. and Candida spp. Diagnostic microbiology of IAIs is complex and plays a relevant role, especially in some situations (e.g. presence of foreign bodies, potential presence of resistant or uncommon pathogens, nosocomial infections in subjects with risk factors). Antibiotic resistance issues are currently encountered in most pathogenic species causing IAIs. Resistance affects all major classes of antimicrobial agents, often involving multiple classes and resulting in complex resistance phenotypes for which only a very limited number of drugs remain active.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622445     DOI: 10.1179/joc.2009.21.Supplement-1.5

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  9 in total

1.  Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus.

Authors:  Mélanie A C Ikeh; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

2.  Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?

Authors:  Puja M Shah; Brandy L Edwards; Zachary C Dietch; Christopher A Guidry; Stephen W Davies; Sara A Hennessy; Therese M Duane; Patrick J O'Neill; Raul Coimbra; Charles H Cook; Reza Askari; Kimberly Popovsky; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-09-23       Impact factor: 2.150

3.  Bacterial species-specific hospital mortality rate for intra-abdominal infections.

Authors:  Jeffrey A Claridge; Aman Banerjee; Katherine B Kelly; William H Leukhardt; Jeffrey W Carter; Manjunath Haridas; Mark A Malangoni
Journal:  Surg Infect (Larchmt)       Date:  2014-05-06       Impact factor: 2.150

4.  In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.

Authors:  Jlenia Brunetti; Chiara Falciani; Giulia Roscia; Simona Pollini; Stefano Bindi; Silvia Scali; Unai Cossio Arrieta; Vanessa Gómez-Vallejo; Leila Quercini; Elisa Ibba; Marco Prato; Gian Maria Rossolini; Jordi Llop; Luisa Bracci; Alessandro Pini
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

5.  Effects of acute intra-abdominal hypertension on multiple intestinal barrier functions in rats.

Authors:  Yuxin Leng; Min Yi; Jie Fan; Yu Bai; Qinggang Ge; Gaiqi Yao
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

6.  Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms.

Authors:  Gil Marcus; Samuel Levy; Ghaleb Salhab; Bethlehem Mengesha; Oran Tzuman; Shira Shur; Erica Burke; Rebecca Cruz Mayeda; Lior Cochavi; Idan Perluk; Ronit Zaidenstein; Tsilia Lazarovitch; Mor Dadon; Dror Marchaim
Journal:  Open Forum Infect Dis       Date:  2016-12-20       Impact factor: 3.835

7.  A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) 2007-2016.

Authors:  Jiangang Zhang; Chunjiang Zhao; Hongbin Chen; Henan Li; Qi Wang; Zhanwei Wang; Feifei Zhang; Hui Wang
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

8.  Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis.

Authors:  Ralph Lohner; Markus Schwederski; Carolin Narath; Johanna Klein; Georg D Duerr; Alexandra Torno; Pascal Knuefermann; Andreas Hoeft; Georg Baumgarten; Rainer Meyer; Olaf Boehm
Journal:  Mediators Inflamm       Date:  2013-07-02       Impact factor: 4.711

9.  Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.

Authors:  Jan De Waele; Jeffrey Lipman; Yasser Sakr; John C Marshall; Philippe Vanhems; Casiano Barrera Groba; Marc Leone; Jean-Louis Vincent
Journal:  BMC Infect Dis       Date:  2014-07-29       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.